Smith Hunter C
Rhythm Pharmaceuticals, Inc. · Chief Financial Officer
Smith Hunter C is listed in filings as Chief Financial Officer at Rhythm Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including sale activity. Recent filings connect the profile to Rhythm Pharmaceuticals, Inc. (RYTM). The current snapshot covers public activity from Feb 14, 2025 to May 20, 2026. Reported amounts are shown as $53.6K to $170.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $171k1.7k shares | SellFeb 19, 2026 | $100.92 | $109.69 | |
| $131k1.3k shares | SellFeb 19, 2026 | $100.27 | $109.69 | |
| $82k800 shares | SellFeb 19, 2026 | $102.10 | $109.69 | |
| $60k585 shares | SellFeb 19, 2026 | $103.28 | $109.69 |